Azidus Laboratories Ltd is a global pharmaceutical and clinical research organisation (CRO) that specialises in supporting the pharmaceutical and biotechnology industry with advanced research and regulatory services. The company is headquartered in Chennai, Tamil Nadu, India, where it operates as a full‑service CRO — offering services such as bioavailability and bioequivalence (BA/BE) studies, clinical trials, clinical data management, pharmacovigilance, and regulatory submission support to drug companies and regulatory authorities around the world. Its Indian facilities adhere to international standards and good clinical practices, and the company is accredited by major regulatory bodies.

In Ghana, Azidus has established a presence through a dedicated unit known as Azidus Ghana, which is located in the Free Zone enclave at Tema. This facility is the first dedicated BA/BE centre in West Africa, purpose‑built to conduct high‑quality clinical and bioanalytical studies locally — a significant step in strengthening clinical research infrastructure in the region. The Ghana unit provides bioequivalence testing, clinical trial support, and other services that help pharmaceutical products meet regulatory requirements.

By combining global expertise with local capacity, Azidus Laboratories Ltd and its Ghana branch contribute to improving access to quality medicines and supporting the region’s participation in clinical research and regulatory science. The company brings international research standards to Ghana, helping drug developers navigate complex regulatory environments and conduct rigorous scientific studies within the country.